欧洲皮肤癌现状与未来挑战
该文指出,三分之一确诊癌症为皮肤癌,欧洲紫外线归因癌症病例数全球领先,黑色素瘤病例数全球最多,角质形成细胞癌(KC)病例数全球第二。预计未来数十年欧洲KC发病率约增加40%、死亡率约增加50%,主要驱动因素为人口老龄化和紫外线暴露。
要点
- 欧洲皮肤癌负担持续上升,KC发病与死亡率预计显著增加
- 紫外线暴露是皮肤癌流行的主要可干预驱动因素
- 呼吁制定欧洲皮肤癌行动计划以降低可避免的紫外线暴露并保障早诊早治
核心结论
- 皮肤癌是当今欧洲癌症领域的重大挑战,并将在未来数十年持续构成挑战。
研究设计与样本
- 原文为综述/评论类文章,未报告系统检索范围与样本量。
主要发现
- 每三例确诊癌症中有一例为皮肤癌。
- 欧洲紫外线归因癌症病例数全球领先,黑色素瘤病例数全球最多,角质形成细胞癌病例数全球第二。
- 预计未来数十年欧洲KC发病率增加约40%,死亡率增加约50%。
- 男性KC死亡率预计接近女性黑色素瘤死亡率。
临床怎么用
- 应推动欧洲皮肤癌行动计划,减少可避免的紫外线暴露,并让医疗体系为皮肤癌的早期诊断和治疗做好准备。
局限性
- 原文未报告研究设计细节、检索范围及样本量等局限性信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
One in every three cancers diagnosed is a skin cancer. Europe has the global lead in the number of UV-attributable cancer cases with the highest number of melanoma cases worldwide and the second highest number of keratinocyte cancers (KC). Further increases are expected in Europe for the coming decades. Projected increases are highest for KC with increases in incidence around 40% and increases in mortality around 50%, with KC mortality in males approximating melanoma mortality in females. The two main drivers for this skin cancer epidemic are ageing of the population but especially UV exposure. In conclusion, skin cancer represents a major challenge in the cancer field in Europe today and will continue to do so in the coming decades. This calls for a European skin cancer action plan intended to reduce avoidable UV exposure and to prepare the healthcare system to safeguard early diagnosis and treatment of skin cancer.
引用
- Brochez L, Volkmer B, Hoorens I, et al. Skin cancer in Europe today and challenges for tomorrow. J Eur Acad Dermatol Venereol. 2024. PMID: 39377431. doi:10.1111/jdv.20368
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。